Premium
Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group
Author(s) -
Toy P.T.C.Y.,
Kaplan E. B.,
McVay P. A.,
Lee S. J.,
Strauss R. G.,
Stehling L. C.
Publication year - 1992
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1046/j.1537-2995.1992.32192116435.x
Subject(s) - medicine , hemoglobin , arthroplasty , surgery , autologous blood , blood loss , blood transfusion , donation , total hip arthroplasty , total hip replacement , blood donor , immunology , economics , economic growth
To determine blood loss, the number of transfusions, and the hemoglobin levels achieved in patients via transfusion in the course of total hip arthroplasty, 324 patient records from 1987 through 1989 were reviewed at three university and three community hospitals. Calculated blood loss was 3.2 ± 1.3 units in primary procedures and 4.0 ± 2.1 units in revision procedures (mean ± SD). Of 777 red cell units transfused, 455 (59%) were autologous units. Transfused patients received 2.0 ± 1.8 units for primary procedures and 2.9 ± 2.3 units for revision procedures (mean ± SD). The maximum number of units given to 95 percent of the transfused patients was 4 for primary procedures and 6 for revision procedures. The mean postoperative hemoglobin level after all transfusions was 103 to 110 g per L, regardless of patient age group of physical status, autologous donor status, or hospital. No difference in length of hospital stay was observed for patients < 65 years old with hemoglobin concentrations of 80 to 139 g per L at discharge.